NEW YORK (GenomeWeb News) – Molecular diagnostics firm Response Genetics said today that it is closing its UK-based facility in a cost-cutting move expected to save $2.3 million annually.

The company disclosed in a filing with the US Securities and Exchange Commission that it has laid off all of its UK employees, a total of nine positions, including James Clark, its UK-based COO.

The reduction in force will be "substantially complete" on March 31, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.